Enhanced exon 2 skipping caused by c.910G>A variant and alternative splicing of MEFV genes in two independent cases of familial Mediterranean fever

References

• Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, et al. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine. 1998;77: 268–97.
   Google Scholar
• Onen F. Familial Mediterrenean fever. Rheumatol Int. 2006;26 :489–96.
   PubMedGoogle Scholar
• Papadopoulos VP, Giaglis S, Mitroulis I, Ritis K. The population genetics of familial Mediterranean fever: a meta-analysis study. Ann Hum Genet. 2008;72:752–61.
   PubMed Web of Science ®Google Scholar
• Cornelius N, Duno M. Molecular evaluation of 458 patients referred with a clinical diagnosis of familial Mediterranean fever in Scandinavia. Rheumatol Int. 2010 (Epub ahead of print).
   Google Scholar
• Halabe-Cherem J, Pére-Jiménez C, Nellen-Hummel H, Mercado-Atri M, Sigala-Rodriguez C, Castafión-Gonthlez J. Familial Mediterranean fever in Mexico city. A 20-year follow up. Cir Cir. 2004;72:135–8.
   PubMedGoogle Scholar
• Tomiyama N, Higashiuesato Y, Oda T, Baba E, Harada M, Azuma M, et al. MEFV mutation analysis of familial Mediter-ranean fever in Japan. Clin Exp Rheumatol. 2008;26:13–7.
   PubMed Web of Science ®Google Scholar
• Sugiura T, Kawaguchi Y, Fujikawa S, Hirano Y, Igarashi T, Kawamoto M, et al. Familial Mediterranean fever in three Jap-anese patients, and a comparison of the frequency of MEFV gene mutations in Japanese and Mediterranean populations. Mod Rheumatol. 2008;18:57–9.
   PubMed Web of Science ®Google Scholar
• Tsuchiya-Suzuki A, Yazaki M, Nakamura A, Yamazaki K, Agematsu K, Matsuda M, Ikeda S. Clinical and genetic features of familial Mediterranean fever in Japan. J Rheumatol. 2009;36: 1671–6.
   Google Scholar
• Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet. 2001;9:473–83.
   PubMed Web of Science ®Google Scholar
• Brik R, Shinawi M, Kepten I, Berant M, Gershoni-Baruch R. Familial Mediterranean fever: clinical and genetic characteriza-tion in a mixed pediatric population of Jewish and Arab patients. Pediatr 1999;103(5). http://www.pediatrics.org/cgi/content/full. 103/5/e70.
   Google Scholar
• Ting JP, Kastner DL, Hoffman HM. CATERPILLERs, pyrin and hereditary immunological disorders. Nat Rev Immunol. 2006;6: 183–95.
   PubMed Web of Science ®Google Scholar
• Chae JJ, Wood G, Richard K, Jaffe H, Colbum NT, Masters SL, et al. The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-KB through its N-terminal frag-ment. Blood. 2008;112:1794–803.
   PubMed Web of Science ®Google Scholar
• Chae JJ, Wood G, Richard K, Park G, Smith BJ, Kastner DL. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL- lbeta production. Proc Natl Acad Sci USA. 2006;103: 9982–7.
   Google Scholar
• Papin S, Cuenin S, Agostini L, Martinon F, Werner S, Beer HD, et al. The SPRY domain of Pyrin, mutated in familial Mediter-ranean fever patients, interacts with inflammasome components and inhibits proIL-lbeta processing. Cell Death Differ. 2007;14: 1457–66.
   PubMed Web of Science ®Google Scholar
• Masumoto J, Taniguchi S, Sagara J. Pyrin N-terminal homology domain- and caspase recruitment damain-dependent oligomeri-zation of ASC. Biochem Biophys Res Commun. 2001;280:652–5.
   Google Scholar
• Richards N, Schaller P, Diaz A, Stuckey J, Shelden E, Wadhwa A, et al. Interaction between pyrin and the apptotic speck protein (ASC) modulates ASC-induced apoptosis. J Biol Chem. 2001;276:39320–9.
   PubMed Web of Science ®Google Scholar
• Mansfield E, Chae JJ, Komarow HD, Brotz TM, Frucht DM, Aksentijevich I, et al. The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments. Blood. 2001;98:851–9.
   PubMed Web of Science ®Google Scholar
• Waite AL, Schaner P, Hu C, Richards N, Balci-Peynircioglu B, Hong A, et al. Pyrin and ASC co-localize to cellular sites that are rich in polymerizing action. Exp Biol Med. 2009;234:40–52.
   Google Scholar
• Tone Y, Wada T, Shibata F, Toma T, Hashida Y, Kasahara Y, et al. Somatic revertant mosaicism in a patient with leukocyte adhesion deficiency type 1. Blood. 2007;109:1182–4.
   PubMed Web of Science ®Google Scholar
• Wada T, Yasui M, Toma T, Nakayama Y, Nishida M, Shimizu M, et al. Detection of T lymphocytes with a second-site mutation in skin lesions of atypical X-linked severe combined immunodeficiency mimicking Omenn syndrome. Blood. 2008;112:1872–5.
   PubMed Web of Science ®Google Scholar
• Mizuno K, Toma T, Tsukiji H, Okamoto H, Yamazaki H, Ohta K, et al. Selective expansion of CD161'ghCCR2- subpopulation of circulating monocytes with preferential production of haem oxygenase (H0)-1 in response to acute inflammation. Clin Exp Immunol. 2005;142:461–70.
   PubMed Web of Science ®Google Scholar
• Subramanian S, Srienc F. Quantitative analysis of transient gene expression in mammalian cells using the green fluorescent pro-tein. J Biotechnol. 1996;49:137–51.
   PubMed Web of Science ®Google Scholar
• Mizuno K, Yachie A, Nagaoki S, Wada H, Okada K, Kawachi M, et al. Oligoclonal expansion of circulating and tissue-infiltrating CD8+ T cells with killer/effector phenotypes in juvenile drematomyositis syndrome. Clin Exp Immunol. 2004;137:187–94.
   PubMed Web of Science ®Google Scholar
• Sabbagh AS, Ghasham M, Khalek RA, Greije L, Shammaa MR, Zaatari GS, et al. MEFV gene mutations spectrum among Leb-anese patients referred for familial Mediterranean fever work-up: experience of a major tertiary care center. Mol Biol Rep. 2008; 35:447–51.
   PubMed Web of Science ®Google Scholar
• Ozdemir 0, Sezgin I, Kurtulgan HK, Candan F, Koksal B, Sumer H, et al. Prevalence of known mutations in the MEFV gene in a population screening with high rate of carriers. Mol Biol Rep. 2010 (Epub ahead of print).
   Google Scholar
• Touitou I, Lesage S, McDermott M, Cuisset L, Hoffman H, Dode C, et al. Infevers: an evolving mutation database for autoin-flammatory syndromes. Hum Mutat. 2004;24:194–8.
   PubMed Web of Science ®Google Scholar
• Milhavet F, Cuisset L, Hoffman HM, Slim R, El-Shanti H, Aksentijevich I, et al. The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat. 2008;29:803–8.
   Google Scholar
• Papin S, Duquesnoy P, Cazeneuve C, Pantel J, Coppey-Moisan M, Dargemont C, et al. Alternative splicing at the MEFV locus involved in familial Mediterranean fever regulates translocation of the marenostrin/pyrin protein to the nucleus. Hum Mol Genet. 2000;9:3001–9.
   Google Scholar
• Diaz A, Hu C, Kastner DL, Schaller P, Reginato AM, Richards N, et al. Lipopolysaccharide-induced expression of multiple alter-natively spliced MEFV transcripts in human synovial fibroblasts: a prominent splice isoform lacks the C-terminal domain that is highly mutated in familial Mediterranean fever. Arthritis Rheum. 2004;50:3679–89.
   PubMedGoogle Scholar
• Centola M, Wood G, Frucht DM, Galon J, Aringer M, Farrell C, et al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood. 2000;95:3223–31.
   PubMed Web of Science ®Google Scholar